The resolution plan of Gurgaon-based Dhanuka Laboratories for the revival of Chennai-based debt-ridden Orchid Pharma Ltd has been implemented, potentially fetching secured lenders around 32.3 per cent recovery. In addition,
The secured lenders will also receive around 4,08,164 equity shares at an issue price of Rs 10 each for part of their debt
First Published: Mar 31 2020 | 8:25 PM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com